Not content with a $1.2 billion licensing deal for Biohaven Pharma's oral migraine therapy rimegepant, Pfizer has just offered to buy the company outright – for a cool $11.6 billion. Pfizer's ...

Pfizer has agreed to pay $60 million to resolve allegations brought by the US government that its Biohaven Pharma subsidiary made improper payments to physicians to boost sales of its migraine ...

Aardvark Therapeutics has followed up filings and speculation with a $94 million initial public offering, putting itself on ...

Defense Secretary Pete Hegseth is holding a news conference Thursday morning from Brussels focusing on the Russia-Ukraine war, which is just over a week from entering its third year. Hegseth’s ...

Rep. Don Bacon (Neb.), a moderate Republican, cautioned against “rewarding the invader” after Defense Secretary Pete Hegseth said returning to its pre-2014 border was an “unrealistic ...

After hours: February 14 at 7:57:59 PM EST ...

Pfizer Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Scrap for the year ending 31-Mar-2024.For the quarter ended 31-12-2024, the company has reported a Standalone Total ...